VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Conference call

<< Previous

Bullboard Posts

Next >>

Comment by G1945Von Apr 04, 2024 10:21am

31 Views

Post# 35970241

RE:RE:Conference call

WalkOverTheStrt wrote: I've personally spoken to Hugh (3 weeks ago) and came away impressed. He in 6 weeks has ramped up incredibly quickly and accomplished some decent early wins/steps. I believe he has the right vision and sales-brand- marketing strategy to get sales ramped. I wasn't impressed with GA or Alvira if that gives any context. I expect 2024 to slowly proceed with some potential wild cards to help drive the stock price but am conservatively looking at 2025 for the real movements.

Isn't Hugh an interim CEO?

G1945V

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida